Sanofi’s Covid Vaccine Inches Closer to the Market, Analyst Says

Sanofi’s Covid Vaccine Inches Closer to the Market, Analyst Says
·3 min read

The results of a Phase 2 trial of the vaccine "are positive signals" for the coming Phase 3 trial, wrote SVB Leerink's Geoffrey Porges.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting